Hyun J, Chaudhuri G, Fukuto J M
Department of Pharmacology, University of California at Los Angeles School of Medicine, Center for the Health Sciences, Los Angeles, California 90095-1735, USA.
Drug Metab Dispos. 1999 Sep;27(9):1005-9.
Nitric oxide (NO) is both an endogenously generated species and the active species released from a variety of important drugs. Due to its endogenous generation and use as a therapeutic agent, the metabolism and fate of NO is of interest and concern. To date, most attention regarding the metabolism and fate of NO has been paid to its oxidized metabolites. Due to the reducing environment of cells, we considered that NO may also undergo reductive metabolism as well. Therefore, we have examined the reductive metabolism of NO by hepatocytes. Generation of nitrous oxide (N(2)O) was used as an indication of NO reduction. Indeed, we observed that NO could be reduced to N(2)O by the cytosolic fraction of hepatocytes. The N(2)O production was partially inhibited by the thiol modifying agent, N-ethylmaleimide and thiol consumption was observed during N(2)O formation. Thus, our results indicate that NO reduction is feasible and likely occurs via a thiol-dependent process.
一氧化氮(NO)既是内源性生成的物质,也是多种重要药物释放出的活性物质。由于其内源生成以及作为治疗剂的应用,NO的代谢和归宿备受关注。迄今为止,关于NO代谢和归宿的大部分关注都集中在其氧化代谢产物上。鉴于细胞的还原环境,我们认为NO也可能进行还原代谢。因此,我们研究了肝细胞对NO的还原代谢。使用一氧化二氮(N₂O)的生成作为NO还原的指标。实际上,我们观察到NO可被肝细胞的胞质部分还原为N₂O。N₂O的产生被硫醇修饰剂N - 乙基马来酰亚胺部分抑制,并且在N₂O形成过程中观察到硫醇消耗。因此,我们的结果表明NO还原是可行的,并且可能通过硫醇依赖性过程发生。